Annual report pursuant to Section 13 and 15(d)

Stockholders' (Deficit) (Details 2)

v3.22.1
Stockholders' (Deficit) (Details 2) - Warrant [Member] - $ / shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Outstanding, beginning 3,333 3,333  
Range of option price per share, outstanding, beginning $ 0.40 $ 0.40  
Weighted Average Exercise Price Outstanding beginning   $ 0.40  
Weighted Average Contractual Life 4 years 8 months 1 day 3 years 6 months 4 years 6 months
Granted 2,871,250  
Range of option price per share, Granted  
Weighted Average Exercise Price, Granted $ 6.97  
Exercised (455,390)    
Range of option price per share, Granted $ 7.43    
Weighted Average Exercise Price, Exercised $ 7.43    
Expired    
Weighted Average Exercise Price, Expired/Cancelled    
Outstanding, ending 2,419,193 3,333 3,333
Range of option price per share, outstanding ending   $ 0.40 $ 0.40
Weighted Average Exercise Price Outstanding ending $ 6.87   $ 0.40
Exercisable, ending 2,419,193    
Weighted Average Exercise Price , Exercisable $ 6.87    
Weighted Average Contractual Life, Exercisable 4 years 8 months 1 day    
Minimum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Range of option price per share, Granted $ 7.43    
Range of option price per share, outstanding ending 7.43    
Range of option price per share, Exercisable 0.40    
Maximum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Range of option price per share, Granted 6.67    
Range of option price per share, outstanding ending 0.40    
Range of option price per share, Exercisable $ 7.43